Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Equity (2016 - 2025)

Historic Return on Equity for Amicus Therapeutics (FOLD) over the last 16 years, with Q3 2025 value amounting to 0.06%.

  • Amicus Therapeutics' Return on Equity rose 6100.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 6100.0%. This contributed to the annual value of 0.32% for FY2024, which is 7500.0% up from last year.
  • As of Q3 2025, Amicus Therapeutics' Return on Equity stood at 0.06%, which was up 6100.0% from 0.19% recorded in Q2 2025.
  • Amicus Therapeutics' 5-year Return on Equity high stood at 0.06% for Q3 2025, and its period low was 1.85% during Q4 2022.
  • Over the past 5 years, Amicus Therapeutics' median Return on Equity value was 0.99% (recorded in 2022), while the average stood at 0.99%.
  • As far as peak fluctuations go, Amicus Therapeutics' Return on Equity crashed by -11200bps in 2022, and later skyrocketed by 8600bps in 2025.
  • Over the past 5 years, Amicus Therapeutics' Return on Equity (Quarter) stood at 0.73% in 2021, then crashed by -153bps to 1.85% in 2022, then surged by 44bps to 1.03% in 2023, then surged by 71bps to 0.3% in 2024, then soared by 79bps to 0.06% in 2025.
  • Its last three reported values are 0.06% in Q3 2025, 0.19% for Q2 2025, and 0.15% during Q1 2025.